Completed PHASE4 INTERVENTIONAL 2-arm NCT01504321

Polycystic Ovary Syndrome - Improving Outcomes

Polycystic Ovary Syndrome - Targeting the Sympathetic Nervous System to Improve Outcomes

Sponsor: Baker Heart and Diabetes Institute

Updated 7 times since 2017 Last updated: Nov 1, 2018 Started: May 31, 2012 Primary completion: May 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Polycystic Ovary Syndrome, this trial is completed. The trial is conducted by Baker Heart and Diabetes Institute and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2020 — Jan 2021 [monthly]

Completed PHASE4
Dec 2018 — Nov 2020 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Dec 2018 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baker Heart and Diabetes Institute

Data source: Baker Heart and Diabetes Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prahran, Australia